JACQUALYN A. FOUSE - Director at AGIOS PHARMACEUTICALS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
AGIO on Nasdaq
All Insider Reports
All Insider Reports

JACQUALYN A. FOUSE - trading volume in the past year for AGIOS PHARMACEUTICALS, INC.

Holdings reported by JACQUALYN A. FOUSE for AGIOS PHARMACEUTICALS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common stock 151,340 $4,134,608 $27.32 20 Jun 2025 Direct
Restricted stock units 0 $0 $35.54 20 Jun 2025 Direct Common stock
Stock options (right to buy) 15,768 18 Jun 2025 Direct Common stock
Stock options (right to buy) 11,774 20 Jun 2024 Direct Common stock

Transactions reported by JACQUALYN A. FOUSE for AGIOS PHARMACEUTICALS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.